大疱性系统性红斑狼疮的临床、组织学、免疫学表现与结局:10例新发病例及118例文献综述
本研究为多中心回顾性研究联合文献综述,纳入10例新发大疱性系统性红斑狼疮(BSLE)患者及文献中118例病例,描述其临床、免疫学、组织学表现与结局。结果显示50%合并狼疮肾炎,69%检出抗VII型胶原抗体,氨苯砜在90%病例中有效。作者认为BSLE是与SLE相关的自身免疫性中性粒细胞性大疱病,氨苯砜为首选。
要点
- BSLE常表现为正常或红斑皮肤上的紧张性大疱,好发于躯干、手臂、头颈部。
- 50%病例合并狼疮肾炎,51%有黏膜受累,31%伴荨麻疹样皮损。
- 直接免疫荧光呈多形性,69%病例检出抗VII型胶原抗体。
核心结论
- 作者认为BSLE是与SLE相关的自身免疫性中性粒细胞性大疱病,而非SLE的皮肤表现,并可能与SLE的活动性皮肤外表现相关。
- 作者认为氨苯砜是BSLE的首选治疗选择。
研究设计与样本
- 多中心回顾性研究联合文献综述,纳入10例新发BSLE患者及系统文献回顾的118例病例。
- 皮肤活检集中复核,并在BSLE发作期采集血清检测循环抗基底膜带抗体。
主要发现
- 10例新发病例均为女性,SLE诊断时中位年龄22岁。
- 50%的病例合并狼疮肾炎。
- BSLE表现为正常或红斑皮肤上的紧张性大疱,主要分布于躯干、手臂、头颈部。
- 31%的病例伴荨麻疹样皮损,51%可见黏膜受累。
- 组织学显示表皮下水疱、真皮中性粒细胞浸润、这些细胞沿基底膜带排列及白细胞碎裂。
关键数值与推荐
- 抗VII型胶原抗体在69%的病例中检出。
- 氨苯砜在90%的病例中有效。
临床怎么用
- 作者认为氨苯砜是BSLE的首选治疗选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Bullous systemic lupus erythematosus (BSLE) is a rare blistering condition associated with systemic lupus erythematosus (SLE). PATIENTS AND METHODS: We conducted a multi-center retrospective study and literature review in order to describe the clinical, immunological, and histological presentations and outcomes of BSLE. The skin biopsies were centrally reviewed, and sera obtained during a flare of BSLE were analyzed for identification of circulating anti-basement membrane zone antibodies. RESULTS: Ten patients (all women, median age at SLE diagnosis of 22 years) were included, as well as 118 cases from a systematic review of the literature. Lupus nephritis was associated in 50% of the cases. BSLE presented as tensed bullae on normal or erythematous skin, predominantly localized on the trunk, arms, head, and neck. Urticarial lesions were associated in 31% of the cases, and mucous membrane involvement was seen in 51%. Histological analyses displayed subepidermal detachment, dermal infiltration of polynuclear neutrophils, alignment of these cells at the basal membrane zone and leukocytoclasis. The direct immunofluorescence was polymorphic, showing linear and/or granular deposits of IgG, IgA, IgM, and/or C3. Anti-type VII collagen antibodies were detected in 69% of cases. Dapsone was efficacious in 90% of cases. CONCLUSION: BSLE is rather an autoimmune neutrophilic blistering disease associated with SLE than a cutaneous manifestation and may be associated with active extra-cutaneous manifestations of SLE. Dapsone is the first-choice option.
引用
- de Risi-Pugliese T, Cohen Aubart F, Haroche J, et al. Clinical, histological, immunological presentations and outcomes of bullous systemic lupus erythematosus: 10 New cases and a literature review of 118 cases. Semin Arthritis Rheum. 2017. PMID: 29191376. doi:10.1016/j.semarthrit.2017.11.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。